The store will not work correctly when cookies are disabled.
3-(5-(4-carbamimidoylphenyl)thiophen-2-yl)quinoline-6-carboximidamide
ID: ALA4875205
PubChem CID: 164626322
Max Phase: Preclinical
Molecular Formula: C21H17N5S
Molecular Weight: 371.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3cnc4ccc(C(=N)N)cc4c3)s2)cc1
Standard InChI: InChI=1S/C21H17N5S/c22-20(23)13-3-1-12(2-4-13)18-7-8-19(27-18)16-10-15-9-14(21(24)25)5-6-17(15)26-11-16/h1-11H,(H3,22,23)(H3,24,25)
Standard InChI Key: LLNKXSQKKKXTOP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
16.8644 -11.7830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5269 -12.5374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0116 -13.2028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7087 -12.6222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3711 -13.3767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5530 -13.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2240 -11.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4017 -12.0416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0683 -12.7961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2459 -12.8809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8334 -13.5968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0274 -13.4243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9385 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2267 -12.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5109 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7992 -12.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0834 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3675 -12.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6516 -12.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9400 -12.1937 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6516 -13.4312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3675 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0834 -10.9562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7992 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5109 -10.9562 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2267 -11.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6929 -12.2686 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
7 8 1 0
8 9 2 0
6 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
19 21 2 0
18 22 1 0
22 23 2 0
16 24 2 0
23 24 1 0
24 25 1 0
25 26 2 0
14 26 1 0
13 27 1 0
10 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 371.47 | Molecular Weight (Monoisotopic): 371.1205 | AlogP: 4.20 | #Rotatable Bonds: 4 |
Polar Surface Area: 112.63 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 11.62 | CX LogP: 3.04 | CX LogD: -1.76 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.32 | Np Likeness Score: -0.57 |
References
1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448] |